Diabetes
Refine Search
Pharmaceutical
Anglo-Swedish pharma major AstraZeneca is to drop the GLP-1 agonist, AZD0186, which had been in a Phase I trial in type 2 diabetes. 21 June 2023
Pharmaceutical
Chinese insulin manufacturer Gan & Lee Pharmaceuticals has sold a 51% stake in its Russian joint venture Endogenix to its partner, the Russian company Pharmaktiv. 20 June 2023
Pharmaceutical
The recent rally in Eli Lilly’s market value, which made it to become the most valuable pharmaceutical company in the world, with a market cap of $420 billion, surpassing Johnson & Johnson, has come as the result of its blockbuster type 2 diabetes (T2D) drug Mounjaro (tirzepatide) successfully completing its second final-stage trial for obesity. 15 June 2023
Pharmaceutical
The Russian government plans to significantly increase public procurement of drugs against diabetes this year despite the existing shortage of funds, reports The Pharma Letter’s local correspondent. 14 June 2023
Biotechnology
Anglo-Swedish pharma major AstraZeneca has entered into a collaboration, exclusive option and license agreement with privately-held UK biopharma Quell Therapeutics. 9 June 2023
Pharmaceutical
Danish diabetes care giant Novo Nordisk has entered into exclusive negotiations for a controlling stake in France-based Biocorp, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in Biocorp. 5 June 2023
Pharmaceutical
Findings of a study funded by the US biotech industry suggest the Inflation Reduction Act could have a negative impact on drug development. 2 June 2023
Pharmaceutical
The US Food and Drug Administration (FDA) on Friday approved Inpefa (sotagliflozin), developed by Lexicon Pharmaceuticals. 27 May 2023
Biotechnology
US clinical-stage biotech Carmot Therapeutics has announced a $150 million oversubscribed and up-sized Series E financing. 27 May 2023
Pharmaceutical
Hefei Tianhui Biotechnology (HTIT) has recently submitted a marketing authorization application (MAA) in China for the world’s first oral insulin for type 2 diabetes (T2D). 26 May 2023
Biosimilars
The European Union must improve its biosimilar medicines policy to increase equity of access and bring much needed savings to healthcare budgets, says Medicines for Europe, the trade group that represents makers of generic and biosimilar medicines in the region. 25 May 2023
Pharmaceutical
Much has been made of the sudden rise in sales of Wegovy (semaglutide) and the weight loss drug’s impact in driving rapid growth at Novo Nordisk. 16 May 2023
Biotechnology
Canada’s Sernova has entered into a pre-clinical research collaboration with AstraZeneca, centered around its Cell Pouch System. 4 May 2023
Pharmaceutical
Danish diabetes care giant Novo Nordisk’s shares were down 4.8% at 1,069.40 kroner this morning, despite the company reporting first-quarter 2023 financials, showing that net sales increased 27% (+25% at constant currencies) to 53,367 million kroner ($7.91 billion). 4 May 2023
Pharmaceutical
Eli Lilly’s tirzepatide moved a step closer to seizing a share of the obesity market on Thursday, when the US drugmaker’s shares were up by more than 2% in early trading. 27 April 2023
Pharmaceutical
Eli Lilly’s gains in the stock market on Thursday were likely mostly down to positive data on investigative drug tirzepatide in obesity. 27 April 2023
Pharmaceutical
Californian specialty drugmaker Amphastar Pharmaceuticals has bought Baqsimi (glucagon) from Eli Lilly, in a deal worth over a billion dollars. 25 April 2023
Biosimilars
South Korean biosimilars company Samsung Bioepis has released the first edition of its Biosimilar Market Report which explores latest market trends for all biosimilars commercially available in the USA. 18 April 2023
Pharmaceutical
French drugmaker Sanofi has signed a three-year Memorandum of Understanding (MoU) with the Ministry of Health of Ghana. 17 April 2023
Pharmaceutical
As interest in GLP-1 agonists soars, AstraZeneca (LSE: AZN) has changed tack, stopping work on a daily injectable option in order to focus on an alternative which requires less regular jabs. 17 April 2023
Generics
Viatris has disclosed that its oral finished-dose manufacturing facility in Indore, India, is subject to regulatory action from the US regulator, after an inspection earlier this year. 24 December 2024
Generics
The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter. 24 December 2024
Pharmaceutical
US pharma major Eli Lilly has recently announced a £279 million ($365.5 million) investment in the UK at the International Investment Summit in London. 19 December 2024
Pharmaceutical
The Egyptian Drug Authority has approved EVA Pharma's insulin glargine injection, marking a significant milestone in its collaboration with US pharma major Eli Lilly. 18 December 2024
Pharmaceutical
The European Commission has approved unconditionally, under the EU Merger Regulation, the proposed acquisition of contract development and manufacture organization (CDMO) Catalent (NYSE: MCTLT) by Denmark’s Novo Holdings. 7 December 2024
Biotechnology
Novavax has agreed to sell its manufacturing plant in the Czech Republic to Novo Nordisk for $200 million. 6 December 2024
Pharmaceutical
Novo Nordisk will reduce the US list prices of two insulin products, Tresiba (insulin degludec) and Fiasp (insulin aspart), by over 70% from 2026. 6 December 2024
Pharmaceutical
Eli Lilly has announced a $3 billion investment to expand its recently acquired manufacturing facility in Wisconsin, USA. 6 December 2024
Pharmaceutical
Danish diabetes and obesity giant Novo Nordisk has announced plans to invest 2.9 billion Danish kroner ($410 million) to establish a cutting-edge quality control laboratory in Hillerød, Denmark. 6 December 2024
Biotechnology
Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies, has entered into a strategic collaboration with Sweden-based NorthX Biologics, a leading biologics manufacturing partner. 4 December 2024
Pharmaceutical
The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing Municipal Bureau of Economy and Information Technology and Beijing Economic and Technological Development Zone today to invest approximately 1 billion euros ($1.05 billion) to establish a new manufacturing base. 3 December 2024
Pharmaceutical
Hua Medicine has announced promising new clinical findings for its glucokinase activator dorzagliatin, presented at the China BioMed Innovation and Investment Conference. 2 December 2024
Pharmaceutical
Australia’s Department of Health and Aged Care has developed a new API (application programming interface) for the efficient distribution of the monthly Pharmaceutical Benefits Scheme (PBS) schedule data. 2 December 2024
Biotechnology
Privately-held UK firm Quell Therapeutics, which positions itself as a pioneer in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, has announced that AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy program. 18 November 2024
Pharmaceutical
French pharma major Sanofi today announced an investment of 40 million euros ($42.4 million) in its Lyon Gerland bioproduction site, consolidating its role as a strategic platform dedicated to immunology. 15 November 2024
Pharmaceutical
Privately-held Montanan firm Microbion has announced promising findings from its Phase II study of pravibismane, a topical treatment aimed at addressing diabetic foot ulcer infections (DFI). 14 November 2024
Pharmaceutical
While sky high expectations for Eli Lilly’s tirzepatide have not yet been realized, more positive data add to a growing sense that the future could be as bright as imagined. 14 November 2024
Pharmaceutical
Germany’s Merck KGaA was trading 5% lower as Thursday’s trading day neared its end, after the company announced its third-quarter financial results and outlook for the rest of the year. 14 November 2024
Pharmaceutical
Anglo-Swedish drugmaker AstraZeneca beat analyst expectations with its third-quarter 2024 revenue and earnings figures. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze